巨球蛋白血症
华登氏巨球蛋白血症
医学
淋巴浆细胞淋巴瘤
嵌合抗原受体
CD19
内科学
免疫学
抗原
多发性骨髓瘤
免疫疗法
淋巴瘤
免疫系统
作者
Éric Durot,Damien Roos‐Weil,Adrien Chauchet,Justine Decroocq,Roberta Di Blasi,Thomas Gastinne,Hedi Bensaber,Morgane Cheminant,Caroline Jacquet,Stéphanie Guidez,François‐Xavier Gros,Emmanuel Bachy,Arthur Coste,Pascale Cony‐Makhoul,Steven P. Treon,Alain Delmer,Ran Reshef,Steven Le Gouill,Jorge J. Castillo,Roch Houot
出处
期刊:Blood
[Elsevier BV]
日期:2024-04-26
卷期号:143 (26): 2804-2807
被引量:5
标识
DOI:10.1182/blood.2024024452
摘要
Histologic transformation of Waldenström macroglobulinemia (HT-WM) carries a poor prognosis with standard treatments. Here, we report the first series of HT-WM treated with chimeric antigen receptor T cells showing a high efficacy and no unexpected toxicity.
科研通智能强力驱动
Strongly Powered by AbleSci AI